442
Views
0
CrossRef citations to date
0
Altmetric
Articles

RETRACTED ARTICLE: Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase

, , ORCID Icon, , , , , , , , , ORCID Icon, , , , , & show all
 

Abstract

Statement of Retraction

The following article has been retracted from publication in the Taylor & Francis journal Hematology:

Guray Saydam, Ibrahim C. Haznedaroglu, Leylagul Kaynar, Akif S. Yavuz, Ridvan Ali, Birol Guvenc, Olga M. Akay, Zafer Baslar, Ugur Ozbek, Mehmet Sonmez, Demet Aydin, Mustafa Pehlivan, Bulent Undar, Simten Dagdas, Orhan Ayyildiz, Diyar Z. Akkaynak, Gulnur Akin & Osman İlhan, Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, Hematology, https://doi.org/10.1080/10245332.2018.1444919. Version of Record published online 27 February 2018.

The above article is being retracted as it it has been brought to the attention of the Editor and Managing Editor of Hematology that it was previously published as: Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, Akif S. Yavuz, Ridvan Ali, Birol Guvenc, Olga M. Akay, Zafer Baslar, Ugur Ozbek, Mehmet Sonmez, Demet Aydin, Mustafa Pehlivan, Bulent Undar, Simten Dagdas, Orhan Ayyildiz, Diyar Z. Akkaynak, Ilkiz M. Dag & Osman Ilhan “Outcomes With Frontline Nilotinib Treatment in Turkish Patients With Newly Diagnosed Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase” Expert Opinion on Pharmacotherapy, volume 17, issue 14, pages 1851-1858, doi: https://doi.org/10.1080/14656566.2016.1219338. The authors had intended to submit a follow-up article to Hematology but inadvertently submitted the same manuscript. The authors have agreed to the publication of this notice.

© Taylor & Francis

View retraction statement:
Statement of Retraction

Additional information

Notes on contributors

Guray Saydam

Guray Saydam is qualified and experienced in CML treatment approach as of all contributor physicians in this study. After he finished his hematology fellowship in 1999, Hematology Unit, Ege University Medical School, he worked as haematologists between 2001 and 2003 at the same clinic and then, he moved to CINJ New Jersey as a postdoctoral fellow in Dr Bertino’s lab. He became associate professor of medicine in 2005 in hematology, and professor of internal medicine at 2011. Currently, he is chair of Hematology Department of Ege University Hospital.

Ibrahim C. Haznedaroglu

Ibrahim C. Haznedaroglu is a scientific contributor to several publications regarding hematological disorders in related high indexed journals.

Leylagul Kaynar

Leylagul Kaynar has been working as hematologist in Erciyes University Medical Faculty Hospital, Kayseri, Turkey.

Akif S. Yavuz

Akif S. Yavuz has been working as hematologist in Istanbul University Istanbul Medical Faculty, Istanbul, Turkey.

Ridvan Ali

Ridvan Ali has been working as hematologist in Department of Internal Medicine, Uludag University Medical Faculty, Bursa, Turkey.

Birol Guvenc

Birol Guvenc is the President of Hematology Specialist Association in Turkey currently. Sixteen physicians from different widespread centers, including medical faculty hospitals and research and training hospitals, conduct the study in an efficacious manner.

Olga M. Akay

Olga M. Akay has been working as hematologist in Department of Internal Medicine, Eskisehir Osmangazi University Medical Faculty Hospital, Eskisehir, Turkey.

Zafer Baslar

Zafer Baslar has been working as hematologist in Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

Ugur Ozbek

Ugur Ozbek has been working as hematologist in Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey.

Mehmet Sonmez

Mehmet Sonmez has been working as hematologist in Department of Internal Medicine, Karadeniz Technical University Medical Faculty, Trabzon, Turkey.

Demet Aydin

Demet Aydin has been working as hematologist in Okmeydani Training and Research Hospital, Istanbul, Turkey.

Mustafa Pehlivan

Mustafa Pehlivan has been working as hematologist in Department of Internal Medicine, Gaziantep University Medical Faculty, Gaziantep, Turkey.

Bulent Undar

Bulent Undar has been working as hematologist in Department of Internal Medicine, Dokuz Eylul University Medical Faculty, Izmir, Turkey.

Simten Dagdas

Simten Dagdas has been working as hematologist in Department of Internal Medicine, Ankara Numune Training and Research Hospital, Ankara, Turkey.

Orhan Ayyildiz

Orhan Ayyildiz has been working as hematologist in Department of Internal Medicine, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey.

Diyar Z. Akkaynak

Diyar Z. Akkaynak has been working as hematologist in Novartis Pharmaceuticals Corporation, Istanbul, Turkey.

Gulnur Akin

Gulnur Akin has been working as hematologist in Novartis Pharmaceuticals Corporation, Istanbul, Turkey.

Osman İlhan

Osman İlhan is a scientific contributor to several publications regarding hematological disorders in related high indexed journals.